Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · IEX Real-Time Price · USD
67.29
-0.58 (-0.85%)
May 2, 2024, 4:00 PM EDT - Market closed

Utah Medical Products Revenue

In the year 2023, Utah Medical Products had annual revenue of $50.22M, a decrease of -3.93%. Revenue in the quarter ending December 31, 2023 was $12.33M, a -9.14% decrease year-over-year.

Revenue (ttm)
$50.22M
Revenue Growth
-3.93%
P/S Ratio
4.84
Revenue / Employee
$297,183
Employees
169
Market Cap
241.50M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202350.22M-2.06M-3.93%
Dec 31, 202252.28M3.23M6.58%
Dec 31, 202149.05M6.88M16.30%
Dec 31, 202042.18M-4.73M-10.08%
Dec 31, 201946.90M4.91M11.68%
Dec 31, 201842.00M584.00K1.41%
Dec 31, 201741.41M2.12M5.38%
Dec 31, 201639.30M-859.00K-2.14%
Dec 31, 201540.16M-1.12M-2.72%
Dec 31, 201441.28M785.00K1.94%
Dec 31, 201340.49M-1.06M-2.55%
Dec 31, 201241.55M3.69M9.75%
Dec 31, 201137.86M12.74M50.71%
Dec 31, 201025.12M-795.00K-3.07%
Dec 31, 200925.92M-1.87M-6.72%
Dec 31, 200827.78M-720.00K-2.53%
Dec 31, 200728.50M-251.00K-0.87%
Dec 31, 200628.75M1.06M3.83%
Dec 31, 200527.69M1.21M4.56%
Dec 31, 200426.49M-652.00K-2.40%
Dec 31, 200327.14M-224.00K-0.82%
Dec 31, 200227.36M407.00K1.51%
Dec 31, 200126.95M-239.00K-0.88%
Dec 31, 200027.19M-2.25M-7.65%
Dec 31, 199929.44M1.77M6.38%
Dec 31, 199827.68M3.41M14.03%
Dec 31, 199724.27M-14.40M-37.24%
Dec 31, 199638.67M-3.37M-8.00%
Dec 31, 199542.04M--
Dec 31, 1994---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AngioDynamics 324.01M
Coherus BioSciences 257.24M
23andMe Holding Co. 247.99M
Puma Biotechnology 235.64M
G1 Therapeutics 84.04M
Codexis 70.14M
AC Immune 17.62M
Veru Inc. 15.93M
Revenue Rankings